Tag: GLP-1

Medical professional discussing GLP-1 medication safety and dosing concerns
Clinical UpdatesPractice

Weight Loss Expert Raises Safety Concerns Over Unregulated GLP-1 ‘Microdoses’

Weight-loss specialist warns about unregulated GLP-1 microdosing trend lacking clinical trial evidence. Long-term safety effects remain unknown for reduced-dose formulations.

By
GMJ Practice Desk
Scientific illustration of brain cells and GLP-1 receptor activity in hypothalamus region
New StudiesResearch Digest

Scientists Discover Why Ozempic and Wegovy Weight Loss Plateaus After Initial Success

NIH scientists have discovered why GLP-1 weight-loss medications like Ozempic and Wegovy eventually plateau, with 47% of patients experiencing reduced…

By
GMJ Research Desk
Medical illustration showing heart protection from GLP-1 medications
New StudiesResearch Digest

GLP-1 Drugs Like Ozempic Cut Heart Attack Risk by 20% in Major Review

Major international review finds GLP-1 drugs like Ozempic reduce heart attack risk by 20% and stroke risk by 18%. The…

By
GMJ Research Desk

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →